Compare CYTK & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | AIZ |
|---|---|---|
| Founded | 1997 | 1892 |
| Country | United States | United States |
| Employees | N/A | 14800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.2B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | AIZ |
|---|---|---|
| Price | $78.68 | $259.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 6 |
| Target Price | $89.26 | ★ $256.83 |
| AVG Volume (30 Days) | ★ 1.7M | 352.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,368,000.00 | N/A |
| Revenue This Year | $7.37 | $7.39 |
| Revenue Next Year | $310.19 | $5.52 |
| P/E Ratio | ★ N/A | $12.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $31.99 | $183.39 |
| 52 Week High | $80.20 | $265.66 |
| Indicator | CYTK | AIZ |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 61.04 |
| Support Level | $59.07 | $207.67 |
| Resistance Level | $79.66 | $260.97 |
| Average True Range (ATR) | 3.20 | 4.88 |
| MACD | 0.51 | 0.04 |
| Stochastic Oscillator | 83.65 | 66.87 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.